Document is current
Any future updates will be listed below
-
Authors
Hettwer, Meike D. http://orcid.org/0000-0002-7973-6752
Dorfschmidt, Lena
Puhlmann, Lara M. C.
Jacob, Linda M.
Paquola, Casey
Bethlehem, Richard A. I. http://orcid.org/0000-0002-0714-0685
Bullmore, Edward T.
Eickhoff, Simon B.
Valk, Sofie L. http://orcid.org/0000-0003-2998-6849
,
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung
Max-Planck-Gesellschaft
S.L.V. was supported by the Max Planck Society through the Otto Hahn Award and the Helmholtz International BigBrain Analytics and Learning Laboratory (Hiball).
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 3 July 2024
First Online: 29 July 2024
Competing interests
: E.T.B. works in an advisory role for Sosei Heptares, Boehringer Ingelheim, GlaxoSmithKline, and Monument Therapeutics. E.T.B. is a stockholder and director of Centile Bioscience Ltd. RAB is a director of and hold equity in Centile Bioscience Ltd. The remaining authors declare no competing interests.
